Biomerica, Inc.

NasdaqCM:BMRA Rapport sur les actions

Capitalisation boursière : US$6.0m

Biomerica Gestion

Gestion contrôle des critères 3/4

Le PDG Biomerica est Zack Irani, nommé en Apr1997, a un mandat de 27.58 ans. La rémunération annuelle totale est $ 360.10K, composée du salaire de 41.7% et des bonus 58.3%, y compris les actions et options de la société. détient directement 6.07% des actions de la société, d'une valeur de $ 379.65K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.1 ans et 7.5 ans.

Informations clés

Zack Irani

Directeur général

US$360.1k

Rémunération totale

Pourcentage du salaire du PDG41.7%
Durée du mandat du directeur général27.6yrs
Propriété du PDG6.1%
Durée moyenne d'occupation des postes de direction3.1yrs
Durée moyenne du mandat des membres du conseil d'administration7.5yrs

Mises à jour récentes de la gestion

Recent updates

Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?

Dec 20
Is Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation

Aug 31
Here's Why We're Watching Biomerica's (NASDAQ:BMRA) Cash Burn Situation

We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate

Mar 04
We're Keeping An Eye On Biomerica's (NASDAQ:BMRA) Cash Burn Rate

Amazon starts selling Biomerica's Aware Breast Self Exam device, EZ Detect test

Sep 29

Biomerica: One To Watch Closely For The Future, But From The Sidelines For Now

Sep 09

Biomerica reports FY results

Aug 29

Biomerica stock jumps after Walmart to begin selling co's Aware Breast Self Exam device

Jul 14

Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable

Dec 03
Most Shareholders Will Probably Find That The CEO Compensation For Biomerica, Inc. (NASDAQ:BMRA) Is Reasonable

Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans

Dec 02
Biomerica (NASDAQ:BMRA) Is In A Good Position To Deliver On Growth Plans

Is Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022

Sep 15

Biomerica (BMRA) Investor Presentation - Slideshow

Jun 14

Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Jun 13
Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook

Apr 04
Biomerica, Inc.'s (NASDAQ:BMRA) Profit Outlook

Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?

Mar 08
Should You Review Recent Insider Transactions At Biomerica, Inc. (NASDAQ:BMRA)?

Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

Feb 10
Companies Like Biomerica (NASDAQ:BMRA) Are In A Position To Invest In Growth

The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders

Jan 15
The Biomerica (NASDAQ:BMRA) Share Price Has Soared 405%, Delighting Many Shareholders

Biomerica soars as its COVID-19 antigen test wins European nod

Jan 12

When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?

Dec 20
When Will Biomerica, Inc. (NASDAQ:BMRA) Become Profitable?

Biomerica clinical trial for IBS nears enrollment completion

Dec 09

How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?

Nov 23
How Much Does Biomerica's (NASDAQ:BMRA) CEO Make?

Analyse de la rémunération des PDG

Comment la rémunération de Zack Irani a-t-elle évolué par rapport aux bénéfices de Biomerica?
DateRémunération totaleSalaireBénéfices de l'entreprise
Aug 31 2024n/an/a

-US$6m

May 31 2024US$360kUS$150k

-US$6m

Feb 29 2024n/an/a

-US$6m

Nov 30 2023n/an/a

-US$6m

Aug 31 2023n/an/a

-US$6m

May 31 2023US$141kUS$141k

-US$7m

Feb 28 2023n/an/a

-US$7m

Nov 30 2022n/an/a

-US$6m

Aug 31 2022n/an/a

-US$5m

May 31 2022US$491kUS$135k

-US$5m

Feb 28 2022n/an/a

-US$4m

Nov 30 2021n/an/a

-US$7m

Aug 31 2021n/an/a

-US$7m

May 31 2021US$488kUS$137k

-US$7m

Feb 28 2021n/an/a

-US$6m

Nov 30 2020n/an/a

-US$5m

Aug 31 2020n/an/a

-US$4m

May 31 2020US$330kUS$137k

-US$2m

Feb 29 2020n/an/a

-US$3m

Nov 30 2019n/an/a

-US$2m

Aug 31 2019n/an/a

-US$2m

May 31 2019US$329kUS$137k

-US$2m

Feb 28 2019n/an/a

-US$2m

Nov 30 2018n/an/a

-US$2m

Aug 31 2018n/an/a

-US$2m

May 31 2018US$295kUS$137k

-US$1m

Rémunération vs marché: La rémunération totale de Zack ($USD 360.10K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 653.78K ).

Rémunération et revenus: La rémunération de Zack a augmenté alors que l'entreprise n'est pas rentable.


PDG

Zack Irani (58 yo)

27.6yrs

Titularisation

US$360,103

Compensation

Mr. Zackary S. Irani, also known as Zack, has been Chief Executive Officer of Biomerica Inc. since April 29, 1997 and is its Director and served as its President. He was Chairman of the Board at Biomerica...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Zackary Irani
CEO & Director27.6yrsUS$360.10k6.07%
$ 362.3k
Allen Barbieri
Executive Vice-Chairman of the Board & Corporate Secretary25.1yrsUS$243.98k0.47%
$ 27.8k
Gary Lu
Principal Accounting Officer & CFO1.7yrsUS$385.64k0%
$ 0
Lucy Liu
Director of Manufacturing & Technical Operationsno datapas de donnéespas de données
Robert Carlson
Chief Commercial Officer2.3yrspas de donnéespas de données

3.1yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Gestion expérimentée: L'équipe de direction de BMRA est considérée comme expérimentée (ancienneté moyenne 3.1 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Zackary Irani
CEO & Directorno dataUS$360.10k6.07%
$ 362.3k
Allen Barbieri
Executive Vice-Chairman of the Board & Corporate Secretary25.1yrsUS$243.98k0.47%
$ 27.8k
Edward Barnholt
Chairman of Strategic Advisory Board8.3yrspas de donnéespas de données
Harry Leider
Member of Strategic Advisory Board6.6yrspas de donnéespas de données
Douglas Drossman
Member of the Scientific Advisory Boardno datapas de donnéespas de données
William Chey
Member of the Scientific Advisory Boardno datapas de donnéespas de données
Jane Emerson
Independent Director17.6yrsUS$137.71k0.42%
$ 25.2k
Anthony Lembo
Member of Scientific Advisory Board8.3yrspas de donnéespas de données
David Moatazedi
Independent Director1.9yrsUS$157.82k0%
$ 0
Catherine Coste
Independent Director4.2yrsUS$145.21k0.26%
$ 15.5k
Brooks Cash
Chairman of Colorectal Screening Scientific Advisory Board3yrspas de donnéespas de données
William Whitehead
Member of the Scientific Advisory Boardno datapas de donnéespas de données

7.5yrs

Durée moyenne de l'emploi

66yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de BMRA sont considérés comme expérimentés (ancienneté moyenne 7.5 ans).